These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 33753502

  • 1. Gain-of-function factor H-related 5 protein impairs glomerular complement regulation resulting in kidney damage.
    Malik TH, Gitterman DP, Lavin DP, Lomax-Browne HJ, Hiemeyer EC, Moran LB, Boroviak K, Cook HT, Gilmore AC, Mandwie M, Ahmad A, Alexander IE, Logan GJ, Marchbank KJ, Bradley A, Pickering MC.
    Proc Natl Acad Sci U S A; 2021 Mar 30; 118(13):. PubMed ID: 33753502
    [Abstract] [Full Text] [Related]

  • 2. Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy.
    Márquez-Tirado B, Gutiérrez-Tenorio J, Tortajada A, Lucientes Continente L, Caravaca-Fontán F, Malik TH, Roldán Montero R, Elías S, Saiz Gonzalez A, Fernández-Juarez G, Sánchez-Corral P, Pickering MC, Praga M, Rodríguez de Córdoba S, Goicoechea de Jorge E.
    J Am Soc Nephrol; 2022 Jun 30; 33(6):1137-1153. PubMed ID: 35545301
    [Abstract] [Full Text] [Related]

  • 3. Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies.
    Loeven MA, Maciej-Hulme ML, Yanginlar C, Hubers MC, Kellenbach E, de Graaf M, van Kuppevelt TH, Wetzels J, Rabelink TJ, Smith RJH, van der Vlag J.
    Front Immunol; 2021 Jun 30; 12():676662. PubMed ID: 34489931
    [Abstract] [Full Text] [Related]

  • 4. C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation.
    Tortajada A, Yébenes H, Abarrategui-Garrido C, Anter J, García-Fernández JM, Martínez-Barricarte R, Alba-Domínguez M, Malik TH, Bedoya R, Cabrera Pérez R, López Trascasa M, Pickering MC, Harris CL, Sánchez-Corral P, Llorca O, Rodríguez de Córdoba S.
    J Clin Invest; 2013 Jun 30; 123(6):2434-46. PubMed ID: 23728178
    [Abstract] [Full Text] [Related]

  • 5. FHR-5 Serum Levels and CFHR5 Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy.
    Garam N, Cserhalmi M, Prohászka Z, Szilágyi Á, Veszeli N, Szabó E, Uzonyi B, Iliás A, Aigner C, Schmidt A, Gaggl M, Sunder-Plassmann G, Bajcsi D, Brunner J, Dumfarth A, Cejka D, Flaschberger S, Flögelova H, Haris Á, Hartmann Á, Heilos A, Mueller T, Rusai K, Arbeiter K, Hofer J, Jakab D, Sinkó M, Szigeti E, Bereczki C, Janko V, Kelen K, Reusz GS, Szabó AJ, Klenk N, Kóbor K, Kojc N, Knechtelsdorfer M, Laganovic M, Lungu AC, Meglic A, Rus R, Kersnik Levart T, Macioniene E, Miglinas M, Pawłowska A, Stompór T, Podracka L, Rudnicki M, Mayer G, Rysava R, Reiterova J, Saraga M, Seeman T, Zieg J, Sládková E, Stajic N, Szabó T, Capitanescu A, Stancu S, Tisljar M, Galesic K, Tislér A, Vainumäe I, Windpessl M, Zaoral T, Zlatanova G, Józsi M, Csuka D.
    Front Immunol; 2021 Jun 30; 12():720183. PubMed ID: 34566977
    [Abstract] [Full Text] [Related]

  • 6. Glomerular Complement Factor H-Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal Impairment.
    Medjeral-Thomas NR, Moffitt H, Lomax-Browne HJ, Constantinou N, Cairns T, Cook HT, Pickering MC.
    Kidney Int Rep; 2019 Oct 30; 4(10):1387-1400. PubMed ID: 31701048
    [Abstract] [Full Text] [Related]

  • 7. von Willebrand factor variants in C3 glomerulopathy: A Chinese cohort study.
    Chen YY, Han SS, Cao Y, Yu XJ, Zhu L, Luo JC, Song WC, Yu F, Mao YH, Zhao MH.
    Clin Immunol; 2021 Aug 30; 229():108794. PubMed ID: 34245915
    [Abstract] [Full Text] [Related]

  • 8. Complement Factor H-Related Proteins FHR1 and FHR5 Interact With Extracellular Matrix Ligands, Reduce Factor H Regulatory Activity and Enhance Complement Activation.
    Papp A, Papp K, Uzonyi B, Cserhalmi M, Csincsi ÁI, Szabó Z, Bánlaki Z, Ermert D, Prohászka Z, Erdei A, Ferreira VP, Blom AM, Józsi M.
    Front Immunol; 2022 Aug 30; 13():845953. PubMed ID: 35392081
    [Abstract] [Full Text] [Related]

  • 9. Complement and kidney disease, new insights.
    Medjeral-Thomas NR, Pickering MC, Cook HT.
    Curr Opin Nephrol Hypertens; 2021 May 01; 30(3):310-316. PubMed ID: 33767058
    [Abstract] [Full Text] [Related]

  • 10. An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.
    Yang Y, Denton H, Davies OR, Smith-Jackson K, Kerr H, Herbert AP, Barlow PN, Pickering MC, Marchbank KJ.
    J Am Soc Nephrol; 2018 Jun 01; 29(6):1649-1661. PubMed ID: 29588430
    [Abstract] [Full Text] [Related]

  • 11. Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy.
    Vernon KA, Ruseva MM, Cook HT, Botto M, Malik TH, Pickering MC.
    J Am Soc Nephrol; 2016 May 01; 27(5):1334-42. PubMed ID: 26374608
    [Abstract] [Full Text] [Related]

  • 12. Liver factor B silencing to cure C3 glomerulopathy: Evidence from a mouse model of complement dysregulation.
    Zanchi C, Locatelli M, Corna D, Cerullo D, Fishilevich E, Desai D, Rottoli D, Donadelli R, Noris M, Zoja C, Remuzzi G, Benigni A.
    Mol Immunol; 2023 Sep 01; 161():25-32. PubMed ID: 37481826
    [Abstract] [Full Text] [Related]

  • 13. Complement and glomerular disease: new insights.
    Pickering M, Cook HT.
    Curr Opin Nephrol Hypertens; 2011 May 01; 20(3):271-7. PubMed ID: 21422921
    [Abstract] [Full Text] [Related]

  • 14. Update on C3 Glomerulopathy.
    Wooden B, Nester CM, Bomback AS.
    Adv Kidney Dis Health; 2024 May 01; 31(3):223-233. PubMed ID: 39004462
    [Abstract] [Full Text] [Related]

  • 15. [Complement system regulation and C3 glomerulopathy].
    Xiao HJ, He RJ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr 18; 45(2):323-6. PubMed ID: 23591359
    [Abstract] [Full Text] [Related]

  • 16. C3 glomerulonephritis and CFHR5 nephropathy.
    Gale DP, Maxwell PH.
    Nephrol Dial Transplant; 2013 Feb 18; 28(2):282-8. PubMed ID: 23125424
    [Abstract] [Full Text] [Related]

  • 17. Homodimeric Minimal Factor H: In Vivo Tracking and Extended Dosing Studies in Factor H Deficient Mice.
    Kamala O, Malik TH, Hallam TM, Cox TE, Yang Y, Vyas F, Luli S, Connelly C, Gibson B, Smith-Jackson K, Denton H, Pappworth IY, Huang L, Kavanagh D, Pickering MC, Marchbank KJ.
    Front Immunol; 2021 Feb 18; 12():752916. PubMed ID: 34956184
    [Abstract] [Full Text] [Related]

  • 18. [Characteristics of pediatric C3 glomerulopathy with decreased factor H in 3 cases].
    He RJ, Xiao HJ, Wang SX, Guan N, Yao Y, Ding J.
    Zhonghua Er Ke Za Zhi; 2012 Dec 18; 50(12):939-43. PubMed ID: 23324154
    [Abstract] [Full Text] [Related]

  • 19. A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry.
    Medjeral-Thomas N, Malik TH, Patel MP, Toth T, Cook HT, Tomson C, Pickering MC.
    Kidney Int; 2014 Apr 18; 85(4):933-7. PubMed ID: 24067434
    [Abstract] [Full Text] [Related]

  • 20. Prevention of Fatal C3 Glomerulopathy by Recombinant Complement Receptor of the Ig Superfamily.
    Wang X, Van Lookeren Campagne M, Katschke KJ, Gullipalli D, Miwa T, Ueda Y, Wang Y, Palmer M, Xing G, Song WC.
    J Am Soc Nephrol; 2018 Aug 18; 29(8):2053-2059. PubMed ID: 29895552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.